首页> 外国专利> PEPTIDES FOR USE IN TOPICAL TREATMENT OF RETINAL NEURODEGENERATIVE DISEASES, IN PARTICULAR EARLY DIABETIC RETINOPATHY AND OTHER RETINAL DISEASES WHERE NEURODEGENERATION PLAYS AN ESSENTIAL ROLE

PEPTIDES FOR USE IN TOPICAL TREATMENT OF RETINAL NEURODEGENERATIVE DISEASES, IN PARTICULAR EARLY DIABETIC RETINOPATHY AND OTHER RETINAL DISEASES WHERE NEURODEGENERATION PLAYS AN ESSENTIAL ROLE

机译:用于视网膜神经退行性疾病,尤其是早期糖尿病性视网膜病变和神经变性在其中发挥重要作用的其他视网膜疾病的局部治疗用肽

摘要

PROBLEM TO BE SOLVED: To provide a tool useful for topically applying peptides and analogs of said peptides to the eye.SOLUTION: A peptide for use in local eye treatment and/or prevention of retinal neurodegenerative diseases, has a sequence length of 13 to 50 amino acids that can reach the retina, in which the N-terminal region of the peptide comprises the sequence: HXaaEGTFTSDXaaSXaaXaa, where Xaais an amino acid selected from alanine and glycine, Xaais an amino acid selected from valine and leucine, Xaais an amino acid selected from serine and lysine, Xaais an amino acid selected from tyrosine and glutamine and the N-terminal residue is a histidine.SELECTED DRAWING: None
机译:解决的问题:提供一种用于将肽和所述肽的类似物局部施用于眼睛的工具。解决方案:用于局部眼部治疗和/或预防视网膜神经退行性疾病的肽,其序列长度为13至50可以到达视网膜的氨基酸,其中肽的N端区域包含以下序列:HXaaEGTFTSDXaaSXaaXaa,其中Xaa是选自丙氨酸和甘氨酸的氨基酸,Xaa是选自缬氨酸和亮氨酸的氨基酸,Xaa是选择的氨基酸Xaa来自丝氨酸和赖氨酸,是一种选自酪氨酸和谷氨酰胺的氨基酸,N端残基是一个组氨酸。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号